COVID-19 has disrupted cancer care in US, Australia, researchers say

Findings by researchers from the University of Sydney and Duke University in the US studying the impact of COVID-19 on cancer treatments say the pandemic has fuelled a shift towards online consultations.

They further revealed that the outbreak of the virus has forced the suspension of research and clinical trials and required doctors to assess the risks of administering standard treatments given cancer patients’ vulnerability to COVID-19.

“In light of physical distancing restrictions due to COVID-19, standard cancer procedures are being altered or delayed, including surveillance imaging; non-emergency surgical procedures; and clinical trials,” said Professor Alex Broom, health sociologist and the lead Sydney researcher.

READ ALSO: COVID-19: S’Korea extends social-distancing rules, as Argentina reports record cases

“The suspension of clinical trials is especially detrimental for patients with rare cancers. For them, enrolling in a clinical trial for a promising new therapy may be the best option.”

However, the team noted that as a result of the pandemic there was also increased identification of non-essential drugs and better identification of treatments which did not offer significant improvements to quality or quantity of life.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now